Cargando…
The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors
SIMPLE SUMMARY: Lung cancer is one of the leading causes of cancer-related mortality worldwide. The incidence of multiple primary lung cancers has been increasing. In addition to the identification of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, the evaluation of the EGFR muta...
Autores principales: | Lee, Hyunwoo, Park, Jin Hee, Han, Joungho, Shim, Young Mog, Kim, Jhingook, Choi, Yong Soo, Kim, Hong Kwan, Cho, Jong Ho, Choi, Yoon-La, Kim, Wan-Seop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221401/ https://www.ncbi.nlm.nih.gov/pubmed/35740676 http://dx.doi.org/10.3390/cancers14123011 |
Ejemplares similares
-
Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
por: Chong, Yousun, et al.
Publicado: (2014) -
Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
por: Lee, Hyunwoo, et al.
Publicado: (2021) -
Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR
por: Ha, Sang Yun, et al.
Publicado: (2015) -
EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital
por: Choi, Yoon-La, et al.
Publicado: (2013) -
Predictors of survival in patients who underwent video‐assisted thoracic surgery talc pleurodesis for malignant pleural effusion
por: Yoon, Dong Woog, et al.
Publicado: (2016)